We used fluorescent probes and EPR to study the mechanism(s) underlying reactive oxygen species (ROS) production by endothelial cell mitochondria and the action of mitoquinol, a mitochondria-targeted antioxidant. ROS measured by fluorescence resulted from complex I superoxide released to the matrix and converted to H 2 O 2 . In contrast, EPR largely detected superoxide generated at complex III and effluxed outward. ROS fluorescence by mitochondria fueled by the complex II substrate, succinate, was substantial but markedly inhibited by rotenone. Superoxide, detected by EPR, in succinate-fueled mitochondria was not inhibited by rotenone and likely derived from semiquinone formation at complex III. Mitoquinol decreased H 2 O 2 fluorescence by succinate-fueled mitochondria but had little effect on the EPR signal for superoxide. This was not associated with a detectable decrease in membrane potential. Mitoquinol markedly enhanced ROS fluorescence in mitochondria fueled by the complex I substrates, glutamate and malate. Inhibitor studies suggested that this occurred in complex I, at one or more Q binding pockets. The above effects of mitoquinol were determined in mitochondria isolated and subsequently exposed to the targeted antioxidant. However, similar effects were observed in mitochondria after antecedent exposure to mitoquinol/mitoquinone in culture, suggesting that the agent is retained after isolation of the organelles. In conclusion, ROS production in bovine aortic endothelial cell mitochondria results largely from reverse transport to complex I and through the Q cycle in complex III. Mitoquinol blocks ROS from reverse electron transport but increases superoxide production derived from forward transport. These effects likely occur at one or more Q binding sites in complex I.
Control of reactive oxygen species (ROS)2 in endothelial cells is particularly important, because endothelial dysfunction, which may be triggered by ROS (1), is a major factor contributing to the development of atherosclerotic heart disease (2-4). Moreover, mitochondrial oxidative damage may underlie problems, including the vascular and neurologic complications of diabetes, cell damage in degenerative diseases, and aging (5-9). Reactive oxygen derived from endothelial cell mitochondria has also been implicated in the metabolic pathways leading to the microvascular complications of diabetes (6).Mitochondrial electron transport generates substantial amounts of superoxide derived from electron leaks as substrates are metabolized (10). The process may have adverse consequences as evidenced by observations in mice lacking the mitochondrial enzyme manganese superoxide dismutase. These mice develop dilated cardiomyopathy and live less than 2 weeks (11). The major sites of superoxide production have been somewhat controversial, but there is evidence that most derive from complexes I and III (12). There is also evidence that complex I superoxide is released exclusively to the matrix side of the inner membrane, whereas complex III likely generates su...